Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.43%
#2 Audiera Audiera +20.35%
#3 Ocean Protocol Ocean Protocol +17.12%
#4 Geodnet Geodnet +14.56%
#5 Arowana Arowana +7.05%
#6 Cysic Cysic +7.00%
#7 Rollbit Coin Rollbit Coin +6.33%
#8 The Bitcoin Bull The Bitcoin Bull +6.07%
#9 Ontology Gas Ontology Gas +5.24%
#10 Perle Perle +4.88%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Instellingen
Taal
DUTCH
Valuta
USD
Thema
RBC Bioscience Corporation RBC Bioscience Corporation

RBC Bioscience Corporation

6848
Rang in aandelen #32481
RBC Bioscience Corporation is a firm dedicated to the research, development,... RBC Bioscience Corporation is a firm dedicated to the research, development, production, and sale of specialized reagents and advanced equipment. These products cater to the life sciences and molecular diagnostic sectors. Its market reach is extensive, covering Europe, the United States, Asia, Taiwan, Africa, and Australia. The company's diverse product line includes reagents tailored for molecular biomedical diagnostics and scientific research, alongside automated instruments for gene and nucleic acid extraction. It also provides a range of nucleic acid extraction kits and associated reagent tissues. Sales are primarily conducted through a global network of distributors. Established in 1995, RBC Bioscience Corporation maintains its headquarters in New Taipei City, Taiwan.
Aandeelprijs
$0.70116857
Marktkapitalisatie
$10.01M
Verandering (1 dag)
0.23%
Verandering (1 jaar)
18.64%
Land
TW
Handel RBC Bioscience Corporation (6848)

Categorie

Healthcare
Winst voor RBC Bioscience Corporation (6848)
Winst in 2026 TTM: 0
Volgens de meest recente financiële verslagen van RBC Bioscience Corporation bedraagt de huidige winst van het bedrijf 0. In 2026 behaalde het bedrijf een winst van 0, gelijk aan de winst van 2026, die 0 bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van RBC Bioscience Corporation van 2026 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR